Dimensional Fund Advisors
AMPE

Dimensional Fund Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Dimensional Fund Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-68
Closed -$26K – 3287
2016
Q2 		$26K Hold
68
– – ﹤0.01% 3280
2016
Q1 		$46K Hold
68
– – ﹤0.01% 3267
2015
Q4 		$72K Hold
68
– – ﹤0.01% 3282
2015
Q3 		$59K Hold
68
– – ﹤0.01% 3332
2015
Q2 		$49K Buy
+68
New +$72.5K ﹤0.01% 3340

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Dimensional Fund Advisors's AMPE Position: Q3 2016 in Review

Dimensional Fund Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2016, closing a stake of 68 shares — an estimated $26K sold.

Dimensional Fund Advisors first reported a position in AMPE in Q2 2015 and held it in 5 quarters. The position peaked at $72K in Q4 2015. 71 funds tracked by Wall St. Rank hold AMPE as of Q3 2016.

  • Dimensional Fund Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2016 after selling out during the quarter.
  • Dimensional Fund Advisors sold 68 Ampio Pharmaceuticals Inc. shares in Q3 2016, an estimated $26K.
  • Dimensional Fund Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q2 2015 and held it in 5 quarters.
  • Dimensional Fund Advisors's Ampio Pharmaceuticals Inc. position peaked at $72K in Q4 2015.
  • 71 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2016.

Based on Dimensional Fund Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.